BURZYKOWSKI, Tomasz

Email Alert RSS Feed

Profile

Full Name
BURZYKOWSKI, Tomasz
Email
tomasz.burzykowski@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Refined By:
Date Issued:  [2000 TO 2009]

Results 21-40 of 103 (Search time: 0.015 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
212008Taxanes alone or in combination with anthracyclines as first-line therapy of patients with metastatic breast cancerPiccart-Gebhart, Martine J.; BURZYKOWSKI, Tomasz; BUYSE, Marc; Sledge, George; Carmichael, James; Luck, Hans-Joachim; Mackey, John R.; Nabholtz, Jean-Marc; Paridaens, Robert; Biganzoli, Laura; Jassem, Jacek; Bontenbal, Marijke; Bonneterre, Jacques; Chan, Stephen; Basaran, Gul Atalay; Therasse, PatrickJournal ContributionA1
222008Individual- and trial-level surrogacy in colorectal cancerBUYSE, Marc; BURZYKOWSKI, Tomasz; Michiels, Stefan; Carroll, KevinJournal ContributionA1
232008A Cross-Validation Study to Select a Classification Procedure for Clinical Diagnosis Based on Proteomic Mass SpectrometryVALKENBORG, Dirk; VAN SANDEN, Suzy; LIN, Dan; KASIM, Adetayo; JANSEN, Ivy; SHKEDY, Ziv; BURZYKOWSKI, Tomasz; HALDERMANS, Philippe; ZHU, QiJournal ContributionA1
242007Finding clusters of positive and negative coregulated genes in gene expression dataKOCH, Kerstin; Schonauer, Stefan; JANSEN, Ivy; VAN DEN BUSSCHE, Jan; BURZYKOWSKI, TomaszProceedings PaperC1
252007Comparison of different estimation procedures for proportional hazards model with random effectsCORTINAS ABRAHANTES, Jose; LEGRAND, Catherine; BURZYKOWSKI, Tomasz; JANSSEN, Paul; Ducrocq, Vincent; DUCHATEAU, LucJournal ContributionA1
262007Using a Poisson approximation to predict the isotopic distribution of sulphur-containing peptides in a peptide-centric proteomic approachVALKENBORG, Dirk; ASSAM NKOUIBERT, Pryseley; Thomas, Gregoire; Krols, Luc; Kas, Koen; BURZYKOWSKI, TomaszJournal ContributionA1
272007Are prostate-specific antigen changes valid surrogates for survival in hormone-refractory prostate cancer? A meta-analysis is needed!Collette, Laurence; BUYSE, Marc; BURZYKOWSKI, TomaszJournal ContributionA1
282007Reintroduction of oxaliplatin is associated with improved survival in advanced colorectal cancerde Gramont, Aimery; BUYSE, Marc; CORTINAS ABRAHANTES, Jose; BURZYKOWSKI, Tomasz; Quinaux, Emmanuel; Cervantes, Andres; Figer, Arie; Lledo, Gerard; Flesch, Michel; Mineur, Laurent; Carola, Elisabeth; Etienne, Pierre-Luc; Rivera, Fernando; Chirivella, Isabel; Perez-Staub, Nathalie; Louvet, Christophe; André, Thierry; Tabah-Fisch, Isabelle; Tournigand, ChristopheJournal ContributionA1
292007The assessment of the usefulness of hemilaminectomy without fenestration in the treatment of thoracolumbar disc disease in chondrodystrophic dogsSterna, J.; BURZYKOWSKI, TomaszJournal ContributionA1
302007Progression-free survival is a surrogate for survival in advanced colorectal cancerBUYSE, Marc; BURZYKOWSKI, Tomasz; Carroll, Kevin; Michiels, Stefan; Sargent, Daniel J.; Miller, Langdon L.; Elfring, Gary L.; Pignon, Jean-Pierre; Piedbois, PascalJournal ContributionA1
312007Testing for trends in dose-response microarray experiments: A comparison of several testing procedures, multiplicity and resampling-based inferenceLIN, Dan; SHKEDY, Ziv; Yekutieli, Dani; BURZYKOWSKI, Tomasz; Goehlmann, Hinrich W. H.; De Bondt, An; Perera, Tim; Geerts, Tamara; BIJNENS, LucJournal ContributionA1
322007Using linear mixed models for normalization of cDNA MicroarraysHALDERMANS, Philippe; SHKEDY, Ziv; VAN SANDEN, Suzy; BURZYKOWSKI, Tomasz; AERTS, MarcJournal ContributionA1
332006Fitting Frailty Models via Linear Mixed Models using Model TransformationMASSONNET, Goele; JANSSEN, Paul; BURZYKOWSKI, TomaszProceedings PaperC1
342006Resampling Plans for Frailty ModelsMASSONNET, Goele; BURZYKOWSKI, Tomasz; JANSSEN, PaulJournal ContributionA1
352006No association of leukemia inhibitory factor (LIF) DNA polymorphisms with multiple sclerosisVANDERLOCHT, Joris; BURZYKOWSKI, Tomasz; SOMERS, Veerle; STINISSEN, Piet; HELLINGS, NielsJournal ContributionA1
362006Prostate-specific antigen (PSA) alone is not an appropriate surrogate marker of long-term therapeutic benefit in prostate cancer trialsCollette, L; BURZYKOWSKI, Tomasz; Schroder, FHJournal ContributionA1
372006A modeling approach to the analysis of nerve regenerative experimentsVAN SANDEN, Suzy; Wouters, Luc; BURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; Van Remoortere, Marie; MEERT, Theo; BIJNENS, LucJournal ContributionA1
382006Surrogate threshold effect: An alternative measure for meta-analytic surrogate endpoint validationBURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
392005Performance of classification methods in microarray settingVAN SANDEN, Suzy; LIN, Dan; BURZYKOWSKI, TomaszJournal ContributionA2
402005New experimental techniques in genomics: challenges for data processing and analysisBURZYKOWSKI, TomaszProceedings PaperC2
show all